Breast Surgery Bulletin

Welcome to the Breast Surgery update produced by the Library & Knowledge Service at East Cheshire NHS Trust

Monday 15 November 2010

BMJ Vol 341 Iss 7781 13 November 2010

Magnetic resonance mammography
Malcolm R Kell

Posted by The Library at 06:21

Labels: Mammography

Newer Post Older Post Home

The Bulletin

We hope that this method of sending you information will be timely and convenient. Please send us your feedback to
ecn-tr.StaffLibrary@nhs.net. You can read this month's bulletin in the main section to the left. You can navigate via subject, content, or date using the links below or use the search box [top left].

About us

The Library & Knowledge Service is located on the 2nd Floor of New Alderley House at Macclesfield District General Hospital.

Ordering articles not available in full text

Email the Library if you need to order any articles, giving full details of: Title; Author; Journal; Date of Publication. We can be contacted on 01625 661362 or by email at ecn-tr.stafflibrary@nhs.net

Athens usernames

You will need an Athens username to access the full text of some articles. You can self register for this at https://openathens.nice.org.uk/ or ask the Library staff for assistance.

Disclaimer

Postings from this bulletin are collated by library staff from a variety of sources but coverage of the topic is not comprehensive.Every effort has been made to ensure that the information provided is accurate, up-to-date and complete. However, articles may contain errors. No responsibility can be accepted for any action taken on the basis of this information.

Blog Archive

► 2023 (36)
- ► July (1)
- ► March (18)
- ► February (10)
- ► January (7)

► 2022 (106)
- ► November (10)
- ► October (7)
- ► September (12)
- ► August (9)
- ► July (8)
- ► May (10)
- ► April (10)
- ► March (12)
- ► February (15)
- ► January (13)

► 2021 (77)
- ► November (10)
- ► October (9)
- ► September (9)
- ► July (11)
- ► June (9)
- ► May (7)
- ► April (13)
- ► February (9)

► 2020 (87)
- ► December (10)
- ► November (13)
- ► October (12)
- ► September (11)
- ► August (8)
- ► July (7)
- ► June (9)
- ► February (11)
- ► January (6)

► 2019 (79)
- ► December (7)
- ► October (7)
- ► August (9)
- ► July (11)
- ► June (8)
- ► May (8)
- ► April (8)
- ► February (13)
- ► January (8)

► 2018 (80)
- ► December (8)
- ► October (7)
- ► September (11)
- ► August (9)
- ► July (10)
- ► May (11)
- ► March (7)
- ► February (9)
- ► January (8)

► 2017 (80)
- ► November (9)
- ► October (7)
- ► September (10)
- ► August (5)
- ► July (11)
- ► May (10)
- ► April (7)
- ► March (8)
- ► February (8)
- ► January (5)

► 2016 (69)
- ► November (9)
- ► October (7)
- ► September (8)
- ► August (7)
- ► July (5)
- ► June (7)
- ► May (6)
- ► April (4)
- ► March (7)
- ► February (9)

► 2015 (63)
- ► December (2)
- ► November (4)
- ► October (8)
- ► September (6)
- ► August (9)
- ► June (5)
- ► May (10)
- ► April (6)
- ► March (2)
- ► February (5)
- ► January (6)

► 2014 (53)
- ► November (5)
- ► October (6)
- ► September (3)
- ► August (5)
- ► July (7)
- ► May (5)
- ► March (6)
- ► February (10)
- ► January (6)

► 2013 (73)
- ► November (10)
- ► October (5)
- ► August (9)
- ► July (6)
- ► June (5)
- ► May (15)
- ► April (9)
- ► March (2)
- ► January (12)

► 2012 (114)
- ► December (3)
- ► November (19)
- ► October (9)
- ► September (11)
- ► August (7)
- ► July (28)
- ► May (8)
- ► April (13)
- ► March (6)
- ► February (9)
- ► January (1)

► 2011 (65)
- ► December (13)
- ► November (7)
- ► September (11)
- ► August (8)
- ► July (1)
- ► June (9)
- ► April (1)
- ► March (4)
- ► February (8)
- ► January (3)

▼ 2010 (55)
- ► December (6)
- ▼ November (4)
- ► October (6)
- ► September (2)
- ► August (3)
- ► July (7)
- ► June (3)
- ► May (8)
- ► April (5)
- ► March (5)
- ► February (3)
- ► January (3)

► 2009 (43)
- ► December (1)
- ► November (9)
- ► October (4)
- ► September (6)
- ► July (4)
- ► June (1)
- ► May (3)
- ► April (3)
- ► March (8)
- ► January (4)

► 2008 (47)
- ► December (3)
- ► November (1)
- ► October (4)
- ► September (3)
- ► August (7)
- ► July (22)
- ► June (7)

Labels (Subject index)

21-gene recurrence score (1)
3-Dimensional conformal radiotherapy (1)
3D breast model (1)
3D imaging (1)
80 and over (1)
A (1)
abdomen; reconstruction (2)
abdominal flap (2)
Abdominal Perforator Exchange (1)
Abemaciclib (3)
Accelerated radiotherapy (1)
Acellular dermal matrix (14)
Acinic cell carcinoma (1)
acupuncture (1)
ADC (1)
ADCC (1)
Adenoid cystic (1)
Adherence (1)
adiposity (1)
Adjuvant (2)
adjuvant chemotherapy (3)
Adjuvant denosumab (1)
Adjuvant hormone therapy (1)
Adjuvant paclitaxel (1)
Adjuvant radiation therapy (1)
adjuvant radiotherapy (5)
adjuvant therapy (3)
adjuvant therapy; premenopausal (1)
adjuvant treatment (2)
Administration (1)
Administration & dosage (1)
Ado-trastuzumab emtansine (1)
adolescent (1)
advanced breast cancer (11)
adverse events (2)
aesthetics (7)
Age (7)
Aged (1)
AI (3)
AJCC staging (1)
AJR [journal] (14)
Allergan Style 410; breast augmentation (1)
AlloDerm (3)
alloplastic breast reconstruction (3)
Alopecia (2)
alpelisib (1)
ambulatory (1)
anaplastic large cell lymphoma (9)
Anastrozole; postmenopausal (1)
anatomical implants (1)
Androgen receptor (1)
Angelina Jolie (1)
Annals of Surgery [journal] (8)
Anti-HER2 antibodies (1)
Antibiotic prophylaxis (5)
Antibody-drug conjugate (4)
Antibody-drug conjugates (1)
antidepressant (1)
Antigen (1)
anxiety (1)
APEX (1)
arm lymphoedema (2)
Arm morbidity (1)
Aromatase inhibitor (2)
art history (1)
artificial intelligence (3)
assessment score (1)
Association of Breast Surgery (2)
ATM (1)
Attendance (1)
atypical hyperplasia (1)
Augmentation (3)
augmentation mastopexy (2)
augmented reality (1)
autologous breast reconstruction (15)
Autologous fat grafts (15)
Axillary dissection (2)
Axillary lymph node (1)
Axillary lymph node dissection (10)
Axillary recurrence (1)
Axillary staging (1)
Axillary surgery (11)
Axillary surgical staging (1)
B (1)
Background parenchymal enhancement (2)
bacterial contamination (1)
BARD1 (1)
Barriers to IBR (1)
batwing mastopexy (1)
BCRAT (1)
benefit (1)
benign macromastia (1)
Benign papilloma (1)
bevacizumab (1)
BI-RADS (1)
BI-RADS Descriptors (2)
BIG 1-98 (1)
bilateral breast carcinoma (1)
Bilateral DIEP flap reconstruction (1)
bilateral mastectomy (2)
Bilateral simultaneous SGAP flaps (1)
biological therapies (1)
Biology (1)
biomarker (3)
Biopsy (1)
Biopsy rate (1)
biosimilar (1)
Bipolar vessel sealing (1)
blood supply (1)
blood test; new drugs (1)
blood-based diagnostic tools (1)
Blue dye alone (1)
BMI (1)
BOADICEA (1)
body image (1)
Body mass index change (1)
Body mass index; breast cancer (1)
bone metastases; breast cancer (1)
Boost (1)
Bostwick; reconstruction (1)
Brachytherapy (1)
Brain metastases (1)
Brain metastasis (2)
BRCA (1)
BRCA gene mutation (1)
BRCA germline mutations (1)
BRCA mutation (5)
BRCA; MRI (2)
BRCA1 (1)
BRCA1/2 mutation (1)
BRCA2 (1)
BRCAPRO (1)
breast (5)
Breast [journal] (15)
breast angiosarcoma (1)
breast attachment (1)
breast augmentation (17)
breast augmentation; mammography (1)
Breast boost radiotherapy (1)
breast cancer (124)
Breast cancer Radiation therapy Radiation recall dermatitis COVID-19 vaccination (1)
Breast cancer care (1)
breast cancer genetics (2)
breast cancer models (1)
breast cancer mortality (4)
breast cancer risk (6)
breast cancer therapy (1)
breast cancer treatment (2)
breast conservation surgery (1)
Breast conservative therapy (9)
breast conserving surgery (19)
breast conserving therapy (2)
breast density (6)
breast implant (7)
breast implants (43)
Breast lesions (2)
Breast masses (1)
Breast neoplasm (2)
breast neoplasms (4)
breast reconstruction (129)
breast reduction (9)
breast screening (15)
breast surgery (18)
breast tumour surgery (1)
Breast ultrasound (1)
breast volume measurement (1)
Breast-conserving surgery (1)
BREAST-Q Score (1)
British Journal of Surgery (5)
buried flap reconstruction (1)
Calcifications (1)
CanAssist Breast (1)
Cancer (1)
Cancer genomics (1)
Cancer screening (1)
Capecitabine (3)
capsular contracture (7)
carcinoma of the breast (1)
Carcinosarcoma (1)
Cardiac morbidity (1)
Cardiac mortality (1)
Cardiac toxicity (1)
Catheterization (1)
CDK4/6 inhibitor (2)
CDK4/6 inhibitors (4)
Cement embolism (1)
CFI-400945 (1)
characteristics (2)
CHEK2 (1)
Chemoprevention (1)
Chemotherapy (26)
chest mass (1)
chest wall (3)
Circulating Tumor DNA (2)
Cisplatin (1)
classification (1)
Clear margin (1)
clinical breast examination (1)
clinical nurse specialist (1)
clinical trials (2)
Clinicopathological features (1)
closed-incision negative-pressure therapy (1)
Cognitive function (1)
cohort (1)
combination therapy (1)
comment (1)
Communication (1)
Community hospitals (1)
Comorbidity (1)
comparison (1)
Compassionate use program (1)
complementary therapy (1)
complications (12)
computer-aided detection (1)
Cone-Beam CT (1)
conference (1)
Confocal microscopy (2)
conservative treatment (1)
CONTACT THE LIBRARY FOR FULLTEXT (6)
contact the library if you want fulltext (4)
Content analysis (1)
contralateral breast cancer (2)
contralateral mastopexy (1)
contralateral prophylactic mastectomy (6)
contralateral reduction mammoplasty (1)
Contrast enhanced sonography (1)
Conventional specimen radiography (1)
correspondence (1)
Cosmetic outcome (3)
cosmetic surgery (1)
cost (2)
Cost analysis (2)
cost effective (2)
Cost-effectiveness (1)
counselling (1)
COVID-19 (5)
CPD (1)
CPS (1)
CRCI (1)
criteria (1)
CRM (1)
crystal; breast ducts (1)
CT imaging (2)
CTCs (1)
cup size (1)
Cure model (1)
Cyclin-dependent kinase 4/6 inhibitors (1)
Cyclophosphamide (1)
CYP2D6 (1)
cystic carcinoma (1)
data (3)
database (2)
day surgery (1)
DCIS (2)
de-escalation (1)
debridement (1)
decision making (2)
Decision-making (1)
decisional conflict (1)
Definition (1)
deformity (1)
density; age (1)
depression (1)
Dermatofibrosarcoma protuberans (1)
diagnosis (5)
Diagnostic accuracy (1)
diagnostic mammography (2)
diagnostic tool (1)
Diarrhoea (2)
DIEAP flap (1)
DIEP flap (2)
DIEP flap reconstruction (22)
Diet (1)
Dietary guidelines (1)
digital breast pathology (1)
Digital Breast Tomosynthesis (8)
digital imaging (1)
direct-to-implant (5)
Disease nodal status (1)
Disease-free survival (1)
distance (1)
distress (1)
DNA (1)
Docetaxel (1)
donor-site morbidity; breast (1)
dose (1)
Dose-response analysis (1)
double-bubble; deformity (1)
drainage (1)
Dressings (1)
Drug development (1)
Drug therapy (1)
Dual HER2 blockade (1)
Dual-phase (1)
dual-plane (1)
ductal carcinoma (1)
Ductal carcinoma in situ (16)
Ductal carcinoma in-situ (2)
dynamic contrast-enhanced MRI (1)
Early breast cancer (9)
early diagnosis (1)
Early phase (1)
Early stage breast cancer (17)
early-stage breast cancer (2)
education (1)
efficacy (1)
Elastography (1)
Elderly (3)
Eligibility criteria (1)
endocrine (2)
endocrine therapy (11)
endocrine treatment (1)
endoscopy-assisted (1)
Enhanced recovery after surgery (2)
Enoxaparin (1)
Epidemiology (2)
ER-postive (1)
ERAS (1)
ErbB-2 (1)
ErbB2 (1)
ERBB2 gene mutations (1)
eribulin (1)
essential amino acids (1)
Estrogen (1)
Estrogen antagonists (1)
Estrogen receptor (1)
Estrogen receptor low-positive (1)
European (1)
evaluation (1)
Executive function (1)
Exemestane (1)
Exercise rehabilitation (2)
expanders (2)
experimental (1)
Extended adjuvant endocrine therapy (1)
Factors (1)
Familial breast cancer (1)
family history (1)
Family history of breast cancer (1)
Fat grafting (11)
fat necrosis (3)
Fatigue (2)
FDC (1)
FDG (1)
Feasibility (1)
fertility (2)
Fibroepithelial lesions (1)
Fibrosis (1)
five-item frailty index (1)
Fixed-dose combination (1)
FLAIR (1)
flap salvage (1)
Food and drug administration (1)
Frail elderly (2)
frailty (1)
Free Flap (6)
Fresh tissue imaging (2)
FROC (1)
fulvestrant (1)
Functional imaging (1)
galactorrhea (1)
Gender-affirming hormone treatment (1)
Gene expression (1)
gene signature (1)
Genetic (1)
Genetic alterations (1)
Genetic assays (1)
Genetic counseling (1)
Genetic risk (7)
Genetic testing (1)
Germline mutation (1)
Global (1)
Goldilocks Procedure (1)
GRADE methodology (1)
graphic abstract (1)
Guidelines (4)
Haemorrhage (1)
Hair loss (1)
Health equity (1)
Health literacy (1)
Health-related quality of life (6)
hematoma (1)
Heparin (3)
HER-2 positive (2)
HER2 (8)
HER2 status (1)
HER2-expressinng breast cancer (1)
HER2-low (2)
HER2-low breast cancer (1)
HER2-negative (9)
HER2-positive (17)
HER2-positive Breast Cancer (3)
HER2-Positive metastatic breast cancer (2)
HER2/PI3K/AKT pathway (1)
HER2+ (1)
Hereditary (1)
Hereditary cancer (2)
High BMI (1)
High Quality Performance Indicators (1)
high risk; postmenopausal (2)
high-riding nipple (2)
Histolog scanner (1)
home-based drug administration (2)
hormone receptor positive breast cancer (4)
Hormone receptor status (1)
hormone therapy (3)
Hormone-receptor positive (1)
hormone-sensitive (1)
hormone; postmenopausal (3)
HQPI (1)
HR positive (1)
HRQoL (2)
HRT (2)
Hyperbaric oxygen therapy (1)
hypofractionation (2)
Hypothyroidism (1)
IBIS (1)
IBR (1)
IC-Score (1)
illness (1)
Image-guided intensity-modulated radiotherapy (1)
Imaging (8)
immediate breast reconstruction (5)
Immune checkpoint inhibition (1)
Immune checkpoint inhibitors (1)
Immunohistochemistry (1)
immunology (1)
Impact of age (1)
implant based (4)
implants (13)
Incidence (2)
incision (2)
Individualized treatment (1)
infection (8)
Inflammatory breast cancer (2)
inflammatory response (1)
Information (1)
Information needs (1)
Iniparib (1)
INSPiRED (1)
Intelligent VAB (1)
Internal mammary node (1)
International (1)
Interval cancer (1)
intracystic papilliary carcinoma (1)
Intravenous (1)
intravenous Tranexamic Acid (1)
invasive breast cancer (1)
invisible surgery (1)
Ipsilateral breast tumor recurrence (1)
Ipsilateral breast tumour recurrences (2)
irradiation (3)
irrigation (1)
ischaemia (2)
journal club (1)
Journal of Medical Screening [journal] (2)
Kings Fund (1)
knowledge gaps (1)
Kyphoplasty (1)
Lancet Oncology [journal] (1)
LAP flap (1)
lapatinib (2)
Lapatinib plus capecitabine (1)
lase interstitial thermotherapy (1)
Latissimus Dorsi (9)
leiomyosarcoma (1)
length of stay (1)
Leser-Trelat (1)
lesions (7)
letrozole (3)
Levels of risk (1)
Lifestyle habit (1)
lipectomy (1)
lipofilling (1)
Liposarcoma (1)
liposomal bupivacaine (1)
Lobular carcinoma (3)
Local ablative therapy (1)
Local ablative treatment (1)
Local recurrence (5)
Local relapse (1)
Localization (1)
Locoregional recurrence (1)
locoregional surgery (3)
Locoregional treatment (1)
Low positive (1)
Luminal androgen receptor subtype (1)
lumpectomy (1)
lymph nodes; postmastectomy (2)
lymphedema (3)
lymphocyte-predominant breast cancer (1)
lymphoedema (8)
Lymphoma (4)
lymphovascular; metastasis (1)
Machine learning (2)
Macromastia (2)
magnetic marker (1)
Magnetic resonance imaging (1)
Mainstream genetic testing (1)
Male breast cancer (2)
malignant breast cancer (1)
Malignant phyllodes tumors (1)
mammaplasty (2)
mammary vessels (1)
Mammographic breast density (1)
Mammographic density (3)
Mammographic screening (1)
Mammography (34)
Margetuximab (1)
Margin assessment (1)
margins (2)
mass screening (1)
mastectom (1)
Mastectomy (62)
mastectomy flap (2)
mastectomy pain (1)
Matrix-producing carcinoma (1)
MBC (1)
measurement (1)
Medication adherence (1)
menopausal (1)
Menopause (1)
mesh (3)
met (1)
meta analysis (6)
Meta-analysis (7)
metastatic breast cancer (22)
Metastatic cancer (1)
Metastatic spine disease (1)
metastatic spread (2)
metastatic triple-negative breast cancer (1)
Metronomic (1)
Microbubbles (1)
microcalcifications (1)
microinvasive (1)
microneedling (1)
microsurgery (4)
microtextured anatomical implants (1)
microvascular breast reconstruction (1)
mitomycin c (1)
Moderate genes (1)
molecular profiling (1)
Mondor's disease (1)
Monoclonal antibody (1)
monotherapy (1)
morbidity (1)
mortality (4)
MR diffusion-weighted imaging (1)
MRI (22)
MRI guided core needle biopsy (2)
Multidisciplinary teams (2)
Multimodality treatment (1)
muscle-sparing (1)
musculoskeletal (1)
NACT (1)
necrosis (4)
Necrosis sign (1)
NEJM (4)
Neo-adjuvant radiotherapy (1)
Neoadjuvant (2)
Neoadjuvant chemotherapy (5)
Neoadjuvant systemic treatment (2)
neoadjuvant therapy (7)
Neoadjuvant therapy Triple-negative breast cancer Network meta-analysis (1)
Neoadjuvant treatment (1)
Neoumbilicus (1)
neratinib (1)
nerve blocks (1)
Nested case-control study (1)
Network meta-analysis (1)
Neutropenia (1)
neutrophil count (1)
New drugs (1)
NHS (2)
Nipple conservation (17)
Nipple reconstruction (9)
nipple sparing mastectomy (5)
Nipple tattoo (2)
nipple-areola complex (6)
nipple-sparing (14)
Nipple-sparing mastectomy (1)
nipple-sparing mastopexy (1)
NK cells (1)
nodal involvement (1)
node-negative (1)
nomenclature (1)
Nomogram (2)
Non-metastatic breast cancer (1)
non-metastatic hormone receptor positive breast cancer (1)
Non-palpable lesion (1)
Non-wired (1)
NOTFULLTEXT (1)
Nutritional intervention (1)
Nutritional status (1)
obese (1)
Obesity (8)
Observatory (1)
Occult metastases (1)
Older (1)
older women (5)
Oligometastases (1)
Oligometastasis (2)
Oligometastatic (1)
Oligometastatic breast cancer (1)
omental fat-augmented free flap (1)
oncologic safety (1)
Oncoplastic (1)
oncoplastic breast conservation (4)
Oncoplastic breast conservation surgery (6)
oncoplastic breast reduction (3)
Oncoplastic surgery (1)
OncotypeDX (1)
Online (1)
online review (1)
Ontruzant (1)
outcomes (4)
output (1)
ovarian failure; chemotherapy (2)
Overall survival (6)
Overall treatment time (1)
oxychlorosene (1)
Paclitaxel (1)
Pain (3)
pain management (2)
pain scores (1)
pain; breast reconstruction (1)
PALB2; breast cancer risk (2)
palbociclib (6)
palpable breast mass (1)
Pandemic (1)
Parenchymal tissue (1)
PARP-Inhibitors (1)
Partial breast irradiation (1)
Partial mastectomy (1)
Partitioned survival approach (1)
Pathologic complete response (3)
Pathological complete response (1)
Pathology (3)
Patient compliance (1)
Patient empowerment (1)
patient reported outcomes (12)
patient satisfaction (2)
Patient support tool (1)
Patient-reported outcome measures (1)
Patients' perspectives (1)
patients' preference (1)
pCR (1)
PD-L1 (1)
pedicle division (1)
pembrolizumab (1)
Percutaneous core biopsy (2)
perforator flap (11)
performance (1)
perfusion flaps (1)
Perioperative breast pain (1)
Peripheral Cytotoxic T Lymphocyte (1)
permanent implant (1)
Persistence (2)
Personalised medicine (1)
Personalized screening (1)
Pertuzumab (3)
PET (1)
PET CT (1)
PET-CT (2)
PET-MR (1)
Pharmacokinetic (1)
Phase II trial (1)
phyllodes tumours of the breast (1)
Physical activity (3)
Physical exercise (1)
Physical therapy modalities (1)
placement (1)
Plastic and Reconstructive Surgery [journal] (14)
Plastic surgery (3)
Platinum (1)
PMMA bone Cement (1)
pocket irrigation (1)
Polo-Like Kinase 4 (1)
Polygenic (1)
Polygenic risk score (1)
polyurethane (1)
Population screening (1)
Population-based (2)
post mastectomy (6)
Post-neoadjuvant (1)
postmastectomy (4)
Postmenopausal (6)
Postoperative breast pain (8)
postoperative expansion (2)
Postoperative radiation therapy (1)
Postoperative recovery (8)
Pprognosis (1)
pre-clinical (1)
precision (1)
Precision oncology (2)
Prediction (2)
Prediction tool (1)
predictive biomarker (1)
Predictive biomarkers (1)
Predictors (1)
Pregnancy (2)
Premenopausal (2)
Preoperative (1)
prepectoral breast reconstruction (15)
prepectoral implant (4)
prepectoral inplant (1)
presurgical (1)
Preventative therapy (1)
prevention (3)
prognosis (8)
Prognostic of young age (1)
Prognostic scoring system (1)
Prognostication (1)
Programmed death-ligand 1 (1)
Progression Free Survival (2)
Progression-free survival (2)
Progression-free survival (PFS) (1)
projection (1)
Propensity matching (1)
Prophylactic mastectomy (9)
prosthesis (4)
Proteasome endopeptidase complex (1)
psychologicalresponse (1)
psychology (1)
Psychosocial outcomes (5)
PTB (1)
ptotic (1)
pyrotinib (1)
Qualitative methods (1)
quality (1)
quality indicators (1)
quality of life (2)
Quantitative (1)
Race (2)
RAD51D (1)
Radiation (2)
Radiation therapy (19)
Radiation toxicity (1)
radiofrequency ablation (1)
Radiofrequency excision biopsy (1)
Radiotherapy (18)
Radiotherapy postmastectomy (7)
Randomized controlled trial (2)
Rapid access gene testing (1)
RCN (1)
RCT (14)
Re-excision (1)
Re-excison (1)
re-exision (1)
Re-operation (1)
Real-world (4)
Receptor (1)
Rechallenge (1)
Reconstruction (40)
recovery (1)
recurrence (8)
Recursive partitioning analysis (1)
red-breast syndrome (1)
reduced surgery (1)
Reduction (2)
Reduction mammaplasty (5)
reflection (1)
Regional lymph node irradiation (1)
Regrowth (1)
Rehabilitation (1)
relapse (1)
removal (1)
replacement (1)
research (4)
Resected triple negative breast cancer (1)
residual disease (1)
Residual tumor cellularity (1)
reverse lymphatic mapping (1)
review (1)
Ribociclib (2)
risk (7)
Risk adaptation (1)
Risk communication (1)
risk factors (1)
Risk reducing mastectomy (1)
risk reduction (1)
Risk reduction bilateral mastectomy (1)
Risk reduction mastectomy (1)
Risk stratification (1)
Risk-stratified screening (1)
robotics (3)
rotation (1)
Sacituzumab govitecan (2)
safety (7)
saline implants (1)
Salivary gland-type tumors (1)
sarcoma; imaging (1)
Sarcopenia (2)
Satisfaction (1)
SB3 (1)
sc-GAP flap (1)
Scalp cooling (1)
scars (5)
Scores (1)
Screening (22)
Screening harms (1)
SEER (2)
Selection of patients (1)
self-examination (1)
sensate breast reconstruction (1)
sensitivity (1)
sensory innervation (4)
sensory nerve coaptation (1)
Sentinel lymph node biopsy (26)
Sentinel lymph node procedure (1)
Sentinel lymph node surgery (5)
Sentinel node biopsy (1)
Sentinel node lymphatic mapping (1)
Sentinel node metastasis (1)
seroma (2)
Serum metabolic biomarkers change (1)
SGAP flap (1)
shape (2)
Shared decision making (1)
Shear wave elastography (1)
Shoulder (1)
Side effects (1)
SIEA flap reconstruction (1)
silent rupture (1)
silicone implants (2)
simulation (1)
Simultaneously integrated boost (1)
Skeletal mass index (1)
skin reduction (1)
skin sparing (2)
Skin-sparing mastectomy (1)
sleep (1)
sleep; chemotherapy (1)
small breast carcinoma (1)
social media (2)
socioeconomic (1)
Socioeconomic status (1)
soft tissue sarcoma (1)
Special types (1)
spinal posture (1)
Squamous cell carcinoma (1)
Stage I–III (1)
Standard of care (1)
statistical modelling (1)
Subcutaneous (1)
subpectoral (3)
subpectoral implant (2)
superior hemimastectomy (1)
support (1)
surface area (1)
surgeon (1)
Surgery (2)
Surgery decision-making (1)
Surgical approach (1)
surgical history (1)
surgical management (3)
surgical margins (1)
surgical simulation (1)
surgical-site infection (2)
Surveillance (2)
survival (7)
Survival outcome (1)
Survival outcomes (1)
survival rates (7)
sutures (1)
symptoms (1)
systematic review (24)
systemic disease (1)
systemic therapy (1)
T-DM1 (2)
Tamoxifen (3)
Tamoxifen; breast reconstruction (3)
Tamoxifen; raloxifene; risk reduction (2)
targeted lymph node biopsy (1)
Targeted surgery (1)
targeted therapy (1)
tattoo (1)
Taxanes (1)
technique (3)
test (1)
textured implants (6)
therapeutic mastectomy (1)
therapy (1)
Thigh or abdominal wall (1)
thigh perforator flap (1)
thrombosis (1)
thyroid (1)
tissue expander (9)
Tissue expander placement (6)
tissue removal; hydrodissection (1)
tools (2)
total breast reconstruction; perforator flap (1)
toxicity (3)
trainer (1)
TRAM flap reconstruction (4)
trans women (1)
transgender (1)
transgender man (2)
transmen (2)
transverse upper gracilis flap (1)
Trastuzumab (8)
Trastuzumab deruxtecan (1)
Trastuzumab emtansine (2)
Trastuzumab subcutaneous (1)
Trastuzumab-deruxtecan (1)
Trastuzumab; breast cancer (8)
Treatment (7)
Treatment efficacy (1)
Treatment late effects (1)
Treatment strategy (1)
trends (1)
triage (1)
triage; new referrals (1)
Triple negative (1)
Triple negative breast cancer (1)
Triple negative invasive lobular carcinoma (1)
Triple-Negative breast cancer (10)
Trop-2 (1)
TSPO (1)
tumescent dissection technique (1)
tumour growth rates (1)
tumour marker (1)
tumour size (2)
Tyrosine kinase inhibitor (1)
ultrasound (3)
Ultrasound elastography (3)
Ultrasound guided fine needle aspiration (1)
Ultrasound guided large needle core biopsy (2)
Under 35 years old (1)
veliparib (1)
venous thromboembolism (1)
venous thromboembolism; mastectomy (1)
Vertebroplasty (1)
Very young patient (1)
video (1)
virtual reality (1)
Web-based decision tools (1)
Weight gain (1)
weight loss (2)
weight-gain (1)
wellbeing (1)
Whole-brain radiotherapy (1)
whole-breast irradiation (1)
Wide local excision (1)
Wise-pattern skin excision (1)
Without chemotherapy (1)
Women (2)
Women's health (1)
wound care (3)
Wound complications (2)
Young breast cancer (1)
young onset (1)
young women (3)
Z-plasty (1)

Simple theme. Theme images by luoman. Powered by Blogger.